These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30374128)

  • 1. Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity.
    Knier B; Hiltensperger M; Sie C; Aly L; Lepennetier G; Engleitner T; Garg G; Muschaweckh A; Mitsdörffer M; Koedel U; Höchst B; Knolle P; Gunzer M; Hemmer B; Rad R; Merkler D; Korn T
    Nat Immunol; 2018 Dec; 19(12):1341-1351. PubMed ID: 30374128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
    Glenn JD; Liu C; Whartenby KA
    J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells mediate tolerance induction in autoimmune disease.
    Wegner A; Verhagen J; Wraith DC
    Immunology; 2017 May; 151(1):26-42. PubMed ID: 28140447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells.
    Parekh VV; Wu L; Olivares-Villagómez D; Wilson KT; Van Kaer L
    J Immunol; 2013 Mar; 190(5):1948-60. PubMed ID: 23345328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2018; 9():1782. PubMed ID: 30123217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model.
    Jiang Q; Duan J; Van Kaer L; Yang G
    Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.
    Ifergan I; Davidson TS; Kebir H; Xu D; Palacios-Macapagal D; Cann J; Rodgers JM; Hunter ZN; Pittet CL; Beddow S; Jones CA; Prat A; Sleeman MA; Miller SD
    J Autoimmun; 2017 Nov; 84():1-11. PubMed ID: 28641926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote control of T
    Vijitha N; Engel DR
    J Leukoc Biol; 2019 May; 105(5):827-828. PubMed ID: 30958568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
    Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudolycorine chloride ameliorates Th17 cell-mediated central nervous system autoimmunity by restraining myeloid-derived suppressor cell expansion.
    Zhang G; Zhu X; Yang F; Li J; Leng X; Mo C; Li L; Wang Y
    Pharm Biol; 2022 Dec; 60(1):899-908. PubMed ID: 36082828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
    Melero-Jerez C; Ortega MC; Moliné-Velázquez V; Clemente D
    Biochim Biophys Acta; 2016 Mar; 1862(3):368-80. PubMed ID: 26527182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system infiltrates are characterized by features of ongoing B cell-related immune activity in MP4-induced experimental autoimmune encephalomyelitis.
    Batoulis H; Wunsch M; Birkenheier J; Rottlaender A; Gorboulev V; Kuerten S
    Clin Immunol; 2015 May; 158(1):47-58. PubMed ID: 25796192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.
    Prinz M; Schmidt H; Mildner A; Knobeloch KP; Hanisch UK; Raasch J; Merkler D; Detje C; Gutcher I; Mages J; Lang R; Martin R; Gold R; Becher B; Brück W; Kalinke U
    Immunity; 2008 May; 28(5):675-86. PubMed ID: 18424188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-derived suppressor cells expressing a self-antigen ameliorate experimental autoimmune encephalomyelitis.
    Casacuberta-Serra S; Costa C; Eixarch H; Mansilla MJ; López-Estévez S; Martorell L; Parés M; Montalban X; Espejo C; Barquinero J
    Exp Neurol; 2016 Dec; 286():50-60. PubMed ID: 27693617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs.
    Won H; Moreira D; Gao C; Duttagupta P; Zhao X; Manuel E; Diamond D; Yuan YC; Liu Z; Jones J; D'Apuzzo M; Pal S; Kortylewski M
    J Leukoc Biol; 2017 Aug; 102(2):423-436. PubMed ID: 28533357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of B cells in multiple sclerosis: rationale for B-cell-targeted therapies.
    Racke MK
    Curr Opin Neurol; 2008 Apr; 21 Suppl 1():S9-S18. PubMed ID: 18388801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell mediated pathogenesis in EAE: Molecular mechanisms.
    Kurschus FC
    Biomed J; 2015; 38(3):183-93. PubMed ID: 25900928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation.
    Hwang D; Seyedsadr MS; Ishikawa LLW; Boehm A; Sahin Z; Casella G; Jang S; Gonzalez MV; Garifallou JP; Hakonarson H; Zhang W; Xiao D; Rostami A; Zhang GX; Ciric B
    Proc Natl Acad Sci U S A; 2022 Apr; 119(14):e2111804119. PubMed ID: 35353625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM-CSF Promotes Chronic Disability in Experimental Autoimmune Encephalomyelitis by Altering the Composition of Central Nervous System-Infiltrating Cells, but Is Dispensable for Disease Induction.
    Duncker PC; Stoolman JS; Huber AK; Segal BM
    J Immunol; 2018 Feb; 200(3):966-973. PubMed ID: 29288202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.